The small cells may express, glial fibrillary acidic protein (GFAP) and desmin in focal areas [9-11]
GLP-1s in CKD: Evidence, market leadership, and key insights from ASN 2025 At ASN Kidney Week 2025, Glucagon-like peptide-1 (GLP-1) receptor agonists moved firmly into the nephrology spotlight, with more than 70 sessions, posters, and oral abstracts probing their role across the kidney-disease continuum, and even a dedicated mention during the opening plenary talk
A partir de esto se concluye que la falta de carnitina en el organismo aumenta el tejido adiposo y reduce la produccin de energa
Clinical data show that dual-pathway activation produces greater weight loss than either compound alone, especially in patients who have adapted to single-agent therapy
The treatments effectiveness is closely tied to your commitment to a healthy diet and regular exercise
Alzheimers Dement (2014) 10(1 Suppl):S4754.10.1016/j.jalz.2013.12.009 73 IwaiTSawabeTTanimitsuKSuzukiMSasaki-HamadaSOkaJ